Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients

Background: Patients with breast cancer (BC) show strong interest in complementary and alternative medicine (CAM), particularly for adverse effects of adjuvant endocrine treatment — e.g., with letrozole. Letrozole often induces myalgia/limb pain and arthralgia, with potential noncompliance and treat...

Full description

Bibliographic Details
Main Authors: C.C. Hack, L. Häberle, S.Y. Brucker, W. Janni, B. Volz, C.R. Loehberg, A.D. Hartkopf, C.-B. Walter, G. Baake, A. Fridman, W. Malter, R. Wuerstlein, N. Harbeck, O. Hoffmann, S. Kuemmel, B. Martin, C. Thomssen, H. Graf, C. Wolf, M.P. Lux, C.M. Bayer, C. Rauh, K. Almstedt, P. Gass, F. Heindl, T. Brodkorb, L. Willer, C. Lindner, H.-C. Kolberg, P. Krabisch, M. Weigel, D. Steinfeld-Birg, A. Kohls, C. Brucker, V. Schulz, G. Fischer, V. Pelzer, B. Rack, M.W. Beckmann, T. Fehm, A. Rody, N. Maass, A. Hein, P.A. Fasching, N. Nabieva
Format: Article
Language:English
Published: Elsevier 2020-04-01
Series:Breast
Subjects:
Breast cancer
Endocrine therapy/treatment
Aromatase inhibitors
Letrozole
Integrative medicine
Complementary and alternative medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977620300011

Internet

http://www.sciencedirect.com/science/article/pii/S0960977620300011

Similar Items